| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/30/1999 | US5888473 Tumor therapy; boron cage compounds |
| 03/30/1999 | CA2125060C Ophthalmic solution for artificial tears |
| 03/30/1999 | CA2099670C Flavor stable zinc acetate compositions for oral absorption |
| 03/30/1999 | CA2093133C Synthetic lung surfactant |
| 03/30/1999 | CA2085975C Dentinal desensitizing compositions |
| 03/26/1999 | CA2248390A1 Complex of human growth hormone and zinc and use |
| 03/25/1999 | WO1999014283A1 Gel-form pressure-sensitive adhesive, and adhesive material and adhesive medicinal preparation both containing the same |
| 03/25/1999 | WO1999014259A1 Degradable poly(ethylene glycol) hydrogels with controlled half-life and precursors therefor |
| 03/25/1999 | WO1999013914A1 Pharmaceutical compositions containing plasma protein |
| 03/25/1999 | WO1999013913A2 High viscosity liquid controlled delivery system as a device |
| 03/25/1999 | WO1999013912A1 Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis |
| 03/25/1999 | WO1999013900A1 Solid pharmaceutical compositions comprising a cyclosporin and an anionic surfactant |
| 03/25/1999 | WO1999013888A1 Germicidal compositions for the treatment of animal infectious diseases of the hoof, comprising a copper salt, a quaternary ammonium compound and a peroxide |
| 03/25/1999 | WO1999013887A1 Burn treatment composition |
| 03/25/1999 | WO1999013886A1 Multiple target hybridizing nucleic acids, their preparation, compositions, formulation, kits and applications |
| 03/25/1999 | WO1999013870A1 Chewing gum containing controlled release acyclic carboxamides |
| 03/25/1999 | WO1999013869A1 Humidity-proof and gastric juice-resistant medications for animals |
| 03/25/1999 | WO1999013868A1 Methods for treating ocular diseases |
| 03/25/1999 | WO1999013867A1 Methods and compositions for treating pulmonary disorders using optically pure (s)-salmeterol |
| 03/25/1999 | WO1999013866A1 Freeze-dried placebo pharmaceutical composition designed to imitate a medicine, in particular based on proteins or polypeptides |
| 03/25/1999 | WO1999013865A1 Sustained-release liposomal anesthetic compositions |
| 03/25/1999 | WO1999013864A2 Solid solution beadlet |
| 03/25/1999 | WO1999013863A1 Ophthalmic composition including a cationic glycoside and an anionic therapeutic agent |
| 03/25/1999 | WO1999013862A2 A pharmaceutical composition for treating dysmenorrhea and premature labor |
| 03/25/1999 | WO1999013857A1 Aqueous solutions of salicylic acid derivatives |
| 03/25/1999 | WO1999013853A1 Triple emulsion containing a solar protecting system |
| 03/25/1999 | WO1999013816A2 Liposomal camptothecin formulations |
| 03/25/1999 | WO1999013812A1 Transdermal administration of ment |
| 03/25/1999 | WO1999013799A1 Synergistic analgesic combination of opioid analgesic and cyclooxygenase-2 inhibitor |
| 03/25/1999 | WO1999013734A1 Chewing gum containing physiological cooling agents |
| 03/25/1999 | WO1999013717A1 A delivery of arginine to cause beneficial effects |
| 03/25/1999 | WO1999001463A3 Modified glycosides, compositions comprised thereof and methods of use thereof |
| 03/25/1999 | WO1999001109A3 Therapeutical system for transdermal delivery of levonorgestrel |
| 03/25/1999 | WO1999000494A3 Cell activation process and reagents therefor |
| 03/25/1999 | WO1999000002A3 Cyclosporin-containing microemulsion preconcentrate composition |
| 03/25/1999 | WO1998056398A3 A method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon |
| 03/25/1999 | WO1998048875A9 Method of delivering halotherapy |
| 03/25/1999 | DE19745890C1 Magnetically locatable and heatable intestinal diagnostic or therapeutic product |
| 03/25/1999 | CA2304312A1 Multiple target hybridizing nucleic acids, their preparation, compositions, formulation, kits and applications |
| 03/25/1999 | CA2304265A1 Methods and compositions for treating pulmonary disorders using optically pure (s)-salmeterol |
| 03/25/1999 | CA2304021A1 Freeze-dried placebo pharmaceutical composition designed to imitate a medicine, in particular based on proteins or polypeptides |
| 03/25/1999 | CA2303936A1 Gel-form pressure-sensitive adhesive, and adhesive material and adhesive medicinal preparation both containing the same |
| 03/25/1999 | CA2303442A1 High viscosity liquid controlled delivery system as a device |
| 03/25/1999 | CA2303366A1 Liposomal camptothecin formulations |
| 03/25/1999 | CA2303178A1 Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis |
| 03/25/1999 | CA2271447A1 Solid pharmaceutical compositions comprising a cyclosporin and an anionic surfactant |
| 03/24/1999 | EP0903151A1 Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms |
| 03/24/1999 | EP0903143A2 Use of daidzein for the manufacture of a medicament for incraesing HDL cholesterol levels |
| 03/24/1999 | EP0902783A1 Hydrolysis-promoting taxane hydrophobic derivatives |
| 03/24/1999 | EP0902777A1 D-mannitol and its preparation |
| 03/24/1999 | EP0902687A1 Polymeric delivery of radionuclides and radiopharmaceuticals |
| 03/24/1999 | EP0902685A1 Ultramicro-emulsions of spontaneously dispersible concentrates containing antitumorally, antivirally and antiparasitically active esters of pentacyclic triterpenes |
| 03/24/1999 | EP0902682A2 Cationic virosomes as transfer system for genetic material |
| 03/24/1999 | EP0902681A1 Inhibition of selectin binding |
| 03/24/1999 | EP0902680A1 Reparation and prevention of fibrotic lesions |
| 03/24/1999 | EP0902664A1 Synchronising of animal oestrus and intra vaginal devices useful therein |
| 03/24/1999 | EP0783297B1 Polyethylene glycol modified ceramide lipids and liposomes |
| 03/24/1999 | EP0765157B1 Pellets |
| 03/24/1999 | EP0679079B1 Solution containing igf-1 |
| 03/24/1999 | EP0673240B1 Stabilized medicinal aerosol solution formulations |
| 03/24/1999 | EP0560937B1 Pharmaceutical compositions |
| 03/24/1999 | CN2311267Y Plaster base |
| 03/24/1999 | CN2311266Y Red powder medicated thread |
| 03/24/1999 | CN1212004A Inorganic pigment microparticles covered with chitin layer |
| 03/24/1999 | CN1211989A Composition and method for delivery of nucleic acids |
| 03/24/1999 | CN1211938A Solid and semi-solid hydrocarbon gels and use thereof |
| 03/24/1999 | CN1211928A Method for enhancing solubility of substantially water-insoluble compounds |
| 03/24/1999 | CN1211927A Fine grain carrier and medicinal composition prepared with use of same |
| 03/24/1999 | CN1211926A Pharmaceutical composition for immunomodulation based on peptides and adjuvants |
| 03/24/1999 | CN1211917A Pharmaceutical composition with base of rhein or diacerhein with improved biological availability |
| 03/24/1999 | CN1211448A 双酵胶囊 Dual yeast capsules |
| 03/24/1999 | CN1211442A Medicated plaster for treating lumbago |
| 03/24/1999 | CN1211440A Pasting preparation for eliminating pain |
| 03/24/1999 | CN1211437A Ointment for treating spur and its preparation method |
| 03/24/1999 | CN1211433A Capsule for removing blood stasis and activating blood flow |
| 03/24/1999 | CN1211430A Evodia rutaecarpa tablet and its preparation technique and application |
| 03/24/1999 | CN1211429A Ointment for decrustation after burn |
| 03/23/1999 | US5886048 PHMB for the treatment of tumor disease |
| 03/23/1999 | US5886045 Administering intramucosally to the nose of the mammal an effective amount of an immunoglobulin e antibody inhibitor (2-(4-(3-ethoxy-2-hydroxypropoxy)phenylcarbamoyl)-ethyl) dimethylsulfonium para-toluenesulfonate compound |
| 03/23/1999 | US5886042 Amphoteric compostion and polymeric forms of alpha hydroxyacids, and their therapeutic use |
| 03/23/1999 | US5886041 Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use |
| 03/23/1999 | US5886039 Administering to uretha a lipophilic active agent selected from the group consisting of vasoactive prostaglandins |
| 03/23/1999 | US5886038 Topically administering to a human a composition having isopropyl myristate as the only active ingredient |
| 03/23/1999 | US5886030 Use of vitamin E tocopheryl derivatives in ophthalmic compositions |
| 03/23/1999 | US5886026 Anti-angiogenic compositions and methods of use |
| 03/23/1999 | US5885982 Use of transglutaminase inhibitor for the treatment of scar tissue |
| 03/23/1999 | US5885978 External therapeutic composition for dermatitis |
| 03/23/1999 | US5885974 Decreases the dosage of bioactive agent necessary, when administered to a patient with abnormal cell metabolism, to correct the abnormal cell metabolism and promote the resumption of normal cell metabolism |
| 03/23/1999 | US5885960 Method of treatment comprising administering a combination comprising FGF and polyelectrolytes |
| 03/23/1999 | US5885957 Treatment of HTLV-I infections |
| 03/23/1999 | US5885629 Mixing the biologically active oil such as oil from seed and flower of ribes, boraginaceae, libitae, curcubitaceae and onagracae species with antioxidant, dispersing this mixture in emulsifier, heating with stirring, mixing with water |
| 03/23/1999 | US5885618 Compressible enzyme powder |
| 03/23/1999 | US5885617 Liquid moisture barrier film coating composition for forming a moisture barrier film coating for pharmaceutical tablets comprising polyvinyl alcohol, soya lecithin, viscosity modifier being xanthan gum, hydroxypropyl-methylcellulose |
| 03/23/1999 | US5885616 Sustained release drug delivery system suitable for oral administration |
| 03/23/1999 | US5885615 Enzyme resist, sustained release pills comprising high viscosity adjuvant |
| 03/23/1999 | US5885614 Odorant inhalation provides an increase in blood flow of penis, and therapeutical aid to stimulate sexual activity and alleviate male vasculogenic impotence |
| 03/23/1999 | US5885613 Lipid, polyethyleneglycol-ceramide conjugate reversibly associated with said lipid to stabilize said lipid in a bilayer structure; drug delivery |
| 03/23/1999 | US5885612 Recrystallization-free estradiol-containing patch |
| 03/23/1999 | US5885611 Bandage-forming gel for oral mucosa |
| 03/23/1999 | US5885601 Delivering antibiotic directly to the uterine cavity or fallopian tube of the female in an amount effective to cause sterilization |